Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-22 | New | $49,999,999 | $49,999,999 | Equity Only | 06b | SEC link |
| 2020-04-07 | New | $5,985,000 | $5,985,000 | Equity Only | 06b | SEC link |
| 2017-08-14 | New | $6,000,000 | $6,000,000 | Equity Only | 06b | SEC link |
| 2016-08-24 | New | $4,041,337 | $4,041,337 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Barry Butler | Executive |
| Fred Eshelman | Director |
| Fredric Eshelman | Director |
| John Gandolfo | Executive |
| Michael Geltzeiler | Director |
| Tsontcho Ianchulev | Director, Executive |
| Rachel Jacobson | Director |
| Hyunsu Jung | Director, Executive |
| Curt La Belle | Director |
| Curt Labelle | Director, Executive |
| Kenneth Lee | Director |
| Ernest Mario | Director |
| Charles Mather | Director |
| Michael Rowe | Director, Executive |
| Ellen Strahlman | Director |
| Anthony Sun | Director |
| Shuhei Yoshida | Director |